Point72 Asset Management »

Nektar Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 189k 56.90

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Arista Networks Com Shs (ANET)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Biogen Idec (BIIB)
Meta Platforms Cl A (META)
Teradyne (TER)
Advanced Micro Devices (AMD)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Airbnb Com Cl A (ABNB)

View all positions for Point72 Asset Management

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics